Cite
HARVARD Citation
Sen, U. et al. (2023). Significance of Oct‐4 transcription factor as a pivotal therapeutic target for CD44+/24− mammary tumor initiating cells: Aiming at the root of the recurrence. Cell biology international. pp. 742-753. [Online].